Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:15:17.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A 403 Forbidden error page was added, showing a 403 header and a Home link, indicating the study record cannot be loaded due to access restrictions.
    Difference
    0.5%
    Check dated 2026-09-30T01:06:20.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error. The previously visible study record for NCT01441947 is no longer accessible on this ClinicalTrials.gov page.
    Difference
    19%
    Check dated 2026-09-23T00:58:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page displays Revision: v3.7.0 instead of v3.6.6, indicating a minor update to the page template or content management system. This change does not alter the study details or results on the page.
    Difference
    0.1%
    Check dated 2026-09-16T00:10:46.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6. This appears to be a minor metadata update and does not modify the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-09-01T19:24:49.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page shows a new revision indicator: v3.6.5, replacing v3.6.4. This reflects an update to the page build rather than any changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-11T08:21:16.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.